Sanofi asks US court to halt diabetes drug patent fight with Mylan Medical Dialogues Bureau12 Feb 2020 10:30 AM IST In a stay application filed on Friday, Sanofi said a recent U.S. Court of Appeals for the Federal Circuit decision upholding the invalidation of two...
Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost Medical Dialogues Bureau30 Dec 2018 9:20 AM ISTZURICH: Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China's Gan...
Biocon, Mylan Present Clinical Data on Insulin Glargine at American Diabetes Associations 77th Scientific Sessions Ruby Khatun Khatun12 Jun 2017 11:29 AM ISTMylan N.V. and Biocon Ltd. announced the presentation of new data from the insulin glargine clinical program, including the INSTRIDE studies at the...
